Roivant Sciences Investor Presentation Deck
September 2022, 21 slides
  1. Roivant Sciences
  2. Related Decks
  3. Investor Presentation Decks
building a leading franchise | Roivant Sciences
forward looking statements | Roivant Sciences
our vision normal lives for people with disease | Roivant Sciences
building a leading anti franchise introducing | Roivant Sciences
inhibition has broad potential in diseases announced indications across multiple therapeutic areas create clinical and commercial opportunity for a franchise approach | Roivant Sciences
anti market is unique in terms of breadth of potential indications and in terms of having a strong | Roivant Sciences
next generation anti | Roivant Sciences
has potentially best in class attributes to address large unmet need in disease compelling patent protection | Roivant Sciences
and demonstrated similar maximum reduction | Roivant Sciences
and placebo demonstrated similar albumin and | Roivant Sciences
is designed to deliver maximum reduction while minimizing interference with the albumin binding site | Roivant Sciences
development is well underway with initial phase data expected in mid | Roivant Sciences
neat franchise strategy | Roivant Sciences
building an anti franchise with differentiated assets to address a range of patient needs | Roivant Sciences
building an anti franchise with differentiated assets and a rational development strategy to optimize ability to address unmet need | Roivant Sciences
planning to leverage data and learnings from to accelerate development of | Roivant Sciences
and have the potential to offer multiple differentiated product features if approved | Roivant Sciences
we believe franchise value is maximized by developing both and | Roivant Sciences
| Roivant Sciences
multiple paths to enhanced value creation when and are developed together | Roivant Sciences
a leader in inhibitor technology dedicated to enabling normal lives for people with diseases | Roivant Sciences
See More
Roivant Sciences
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Autoimmune
Clinical trial
Related decks
Immix Biopharma
Investor Presentation
March 2024
argenx SE
Results
October 2022
argenx SE
Results
July 2023
Xeris Biopharma
Investor Presentation
October 2022
Genelux
Investor Presentation
February 2024
argenx SE
Investor Presentation
March 2023
uBiome
Start Up
June 2017
Nuvalent
Investor Presentation
January 2024
Immix Biopharma
Investor Presentation
March 2024
argenx SE
Results
October 2022
argenx SE
Results
July 2023
Xeris Biopharma
Investor Presentation
October 2022
Genelux
Investor Presentation
February 2024
argenx SE
Investor Presentation
March 2023
uBiome
Start Up
June 2017
Nuvalent
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights